Grant As Part Of Neoantigen Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Achilles Therapeutics Receives Horizon 2020 Grant as Part of Neoantigen Consortium
Research and Innovation program to develop a tool for the prediction of neoantigen immunogenicity
LONDON, May 06, 2021 (GLOBE NEWSWIRE) Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that it is a member of a consortium that has been awarded a grant from Horizon 2020, an EU Research and Innovation program. The consortium, which is led by UCL and includes The Francis Crick Institute, the Weizmann Institute of Science, and the Technical University of Denmark, in addition to Achilles, will research the immunogenicity of tumor neoantigens with the aim of developing a tool to predict neoantigen immunogenicity. ....

United Kingdom , City Of , Sergio Quezada , Melissa Gardiner , Mary Jane Elliott , Sukaina Virji , European Union Horizon , Grant As Part Of Neoantigen Consortium , Weizmann Institute Of Science , Ir External Communications , Innovation Union , Consortium Members , Francis Crick Institute , Eu Research , Consilium Strategic Communications , Technical University Of Denmark , Achilles Therapeutics Receives Horizon , Weizmann Institute , Technical University , Chief Scientific Officer , European Union , Jane Elliott , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , செர்ஜியோ க்வெஸாட , மெலிசா தோட்டக்காரர் ,